Home/Pipeline/GammaTile Therapy

GammaTile Therapy

Operable Brain Tumors (Newly diagnosed & recurrent glioblastoma, brain metastases, recurrent meningiomas)

CommercialActive

Key Facts

Indication
Operable Brain Tumors (Newly diagnosed & recurrent glioblastoma, brain metastases, recurrent meningiomas)
Phase
Commercial
Status
Active
Company

About GT Medical Technologies

GT Medical Technologies is a commercial-stage private company pioneering a novel approach to intraoperative radiation therapy for brain tumors. Its core innovation, GammaTile, is a tile-shaped, bioresorbable collagen carrier pre-loaded with Cesium-131 radiation seeds, which surgeons implant at the tumor resection site. This technology eliminates the typical post-surgical delay for external beam radiation, provides highly conformal dose delivery to reduce recurrence, and aims to spare healthy brain tissue. The company is currently focused on commercializing GammaTile for recurrent and newly diagnosed malignant brain tumors, including glioblastoma, brain metastases, and recurrent meningiomas.

View full company profile